Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency

Haematologica

Volumn 85, Issue 11 SUPPL., 2000, Pages 41-46

  Lanfranchi, A ^a   Verardi, R ^a   Tettoni, K ^a   Neva, A ^a   Mazzolari, E ^a   Pennacchio, M ^a   Pasic, S ^a   Ugazio, A G ^a   Albertini, A ^a   Porta, F ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Bone marrow transplantation; Peripheral blood stem cells; Primary immunodeficiency

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; CHILDHOOD DISEASE; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CRYOPRESERVATION; DONOR; FEMALE; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; HUMAN CELL; INFANT; MALE; PRESCHOOL CHILD;

FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; MALE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033694554     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Report of a WHO Scientific Group: Primary immunodeficiency disease
2. Transplantation
3. Unrelated (URD) bone marrow transplantation for primary immunodeficiencies: An international review
4. Bone marrow transplantation in Europe for primary immunodeficiencies other than severe combined immunodeficiency: A report from the European Group for BMT and the European Group for Immunodeficiency
5. Purified CD34+ blood stem cells from HLA-haploidentical parental donors for transplantation in SCID
6. Allogenic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts
7. Successful engraftment of T-cell depleted haploidentical 'three-loci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum
8. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells
9. Addition of Thiotepa improves results in T-cell depleted bone marrow transplant for advanced leukemia
10. Bone marrow transplantation monitoring by DNA analysis
11. Control of graft-versus-host disease and graft rejection by T-cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases
12. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep blood cells
13. Design of large-scale separation system for positive and negative immunomagnetic selection of cells using super-paramagnetic microspheres
14. Probability of finding HLA-matched unrelated donors
15. European experience of bone marrow transplantation for severe combined immunodeficiency
16. The host barrier in animal models of T-cell depleted allogenic bone marrow transplantation
17. Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T cells and allore-active cytotoxic precursors
18. Bone marrow transplantation from genetically HLA-non identical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: Use of two monoclonal antibodies to prevent graft rejection
19. Marrow transplants From HLA haploidentical donors: Failure to engraft and late graft failure
20. Transplantation of marrow depleted of T cells by soybean lecitin agglutination and E-rosette depletion: Major histocompatibility complex-related graft resistance in leukemic transplant recipients
21. Graft rejection in recipients of T-cell depleted HLA-non-identical marrow transplants for leukemia: Identification of host derived anti-donor allocytotoxic T-lymphocytes
22. Pre-transplant conditioning with busulfan and cyclophosphamide for non-malignant disesaes
23. Enhancemenet of T-cell depleted bone marrow allografts in mice by Thiotepa
24. Reconstitution of the immune system after unrelated or partially matched T-cell depleted bone marrow transplantation in children: Immunophenotypic analysis and factors affecting the speed of recovery
25. The biology and clinical use of blood stem cells
26. Immune reconstitution following peripheral blood stem cells transplantation, autologous'bone marrow transplantation and allogenic bone marrow transplantation
27. Combined transplantation of allogenic bone marrow and CD34+ blood cells
28. Hematopoietic and stromal reconstitution after haploidentical allogenic bone marrow transplantation
29. Purified CD34+ blood stem cells from HLA-haploidentical parental donors for transplantation in SCID
30. A comparative study of the phenotype and proliferative capacities of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and marrow CD34+ cells
31. Peripheral blood progenitor cells mobilized by recombinant human granulocyte colony-stimulating factor plus recombinant rat stem cell factor contain long term engrafting cells capable of cellular proliferation for more than two years as shown by serial transplantation in mice
32. Long-term maintenance of hematopoiesis by irradiated mice by retrovirally transduced peripheral blood stem cells
33. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long term engraftment after autologous transplantation
34. Autologous transplantation with peripheral blood stem cells: A review of clinical results
35. Allogenic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia
36. Autografting For patients with chronic myeloid leukemia in chronic phase: Peripheral blood stem cells may have a finite capacity for mantaining hematopoiesis